{
    "clinical_study": {
        "@rank": "126159", 
        "arm_group": [
            {
                "arm_group_label": "Iconacy Hip System", 
                "arm_group_type": "Active Comparator", 
                "description": "Iconacy hip system prosthesis components"
            }, 
            {
                "arm_group_label": "Stryker Accolade Hip System", 
                "arm_group_type": "Active Comparator", 
                "description": "Stryker Accolade hip system prosthesis components"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the use and efficacy of the Iconacy Hip System for\n      total hip replacement surgery."
        }, 
        "brief_title": "Post-Market Study of the ICONACY Hip System", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Degenerative Joint Disease", 
        "condition_browse": {
            "mesh_term": [
                "Joint Diseases", 
                "Osteoarthritis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  This must be a primary hip replacement on this hip\n\n          -  Patient is 30 years of age or older\n\n          -  Have hip joint disease related to one or more of the following: degenerative joint\n             disease, including osteoarthritis or traumatic arthritis\n\n          -  Patient is likely to be available for evaluation for the duration of the study\n\n          -  Able and willing to sign the informed consent and follow study procedures\n\n        Exclusion Criteria:\n\n          -  Is younger than 30 years of age\n\n          -  If there has been a total hip replacement on this hip in the past (no revisions\n             allowed in study)\n\n          -  Infection, or history of infection, acute or chronic, local or systemic\n\n          -  Alcoholism or other addictions\n\n          -  Muscular, neurological or vascular deficiencies which compromise the affected\n             extremity\n\n          -  Obesity(BMI>45)\n\n          -  Insufficient bone quality\n\n          -  Loss of ligamentous structures\n\n          -  High levels of physical activity\n\n          -  Materials sensitivity\n\n          -  Prisoner\n\n          -  Mental conditions that may interfere with the patient's ability to give an informed\n             consent or willingness to fulfill the study requirements\n\n          -  Patient is pregnant\n\n          -  Is not able to read English language"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "0", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02027974", 
            "org_study_id": "13-1-M-239"
        }, 
        "intervention": [
            {
                "arm_group_label": "Iconacy Hip System", 
                "description": "Comparison of Iconacy I-Hip system to the Stryker Accolade hip system using a randomized study.", 
                "intervention_name": "Iconacy Hip System", 
                "intervention_type": "Device", 
                "other_name": [
                    "Iconacy I-Hip", 
                    "I-Hip", 
                    "iHip"
                ]
            }, 
            {
                "arm_group_label": "Stryker Accolade Hip System", 
                "description": "Comparison of Iconacy I-Hip system to the Stryker Accolade hip system using a randomized study.", 
                "intervention_name": "Stryker Accolade Hip System", 
                "intervention_type": "Device", 
                "other_name": "Accolade"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Hip", 
            "Arthroplasty", 
            "Arthroplasties", 
            "Prosthesis", 
            "Iconacy", 
            "Osteoarthritis", 
            "Arthritis", 
            "THA", 
            "THR", 
            "DJD"
        ], 
        "lastchanged_date": "May 12, 2014", 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "ICONACY Hip Clinical Data Acquisition (13-1-M-239)", 
        "overall_official": {
            "affiliation": "Eastern Maine Medical Center", 
            "last_name": "William A Hodge, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Withdrawn", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Radiographic success", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Harris Hip Score must be > or = 80 at 2 years", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Oxford Hip Score > 40 points at 2 years", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02027974"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Patient Satisfaction at 1, 2, and 3 years", 
                "safety_issue": "No", 
                "time_frame": "1, 2, and 3 years"
            }, 
            {
                "measure": "Improvement in Harris Hip Score from pre-surgery to 1, 2, and 3 years", 
                "safety_issue": "No", 
                "time_frame": "1, 2, and 3 years"
            }, 
            {
                "measure": "Improvements in Oxford Hip Score from pre-survey to 1, 2, and 3 years", 
                "safety_issue": "No", 
                "time_frame": "1, 2, and 3 years"
            }
        ], 
        "source": "Iconacy Orthopedic Implants, LLC.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Iconacy Orthopedic Implants, LLC.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}